Cullinan Management (CGEM) Stock Forecast & Price Target

Compare

309 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CGEM Analyst Ratings

Strong Buy

9 Buy

0 Hold

0 Sell

Based on 9 analysts giving stock ratings to

Cullinan

Management

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CGEM Stock 12 Month Forecast

Average Price Target

$30.25

▲(194.83% Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Cullinan Management in the last 3 months. The average price target is $30.25 with a high forecast of $38.00 and a low forecast of $23.00. The average price target represents a 194.83% change from the last price of $10.26.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","22":"$22","39":"$39","13.5":"$13.5","30.5":"$30.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$38.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":30.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$30.25</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$23.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,13.5,22,30.5,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.75,12.846153846153847,14.942307692307693,17.03846153846154,19.134615384615387,21.230769230769234,23.326923076923077,25.423076923076923,27.51923076923077,29.615384615384617,31.711538461538463,33.80769230769231,35.90384615384615,{"y":38,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.75,12.25,13.75,15.25,16.75,18.25,19.75,21.25,22.75,24.25,25.75,27.25,28.75,{"y":30.25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.75,11.692307692307692,12.634615384615385,13.576923076923077,14.51923076923077,15.461538461538462,16.403846153846153,17.346153846153847,18.28846153846154,19.23076923076923,20.173076923076923,21.115384615384613,22.057692307692307,{"y":23,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":15.78,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.18,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.56,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.49,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.52,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.75,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.64,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.67,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.49,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.66,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.75,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$38.00

Average Price Target$30.25

Lowest Price Target$23.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Marc Frahm

TD Cowen

Buy

―

Reiterated

12/17/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Cullinan Management (NASDAQ: CGEM)

Kaveri Pohlman

Clear Street

$22→$33

Buy

221.64%

Upside

Reiterated

12/10/25

Cullinan Therapeutics price target raised to $33 from $22 at Clear StreetCullinan Therapeutics price target raised to $33 from $22 at Clear Street

Julian Harrison

BTIG

$38

Buy

270.37%

Upside

Reiterated

12/09/25

Cullinan Management (CGEM) Gets a Buy from BTIG

Sean Laaman

Morgan Stanley

$28

Buy

172.90%

Upside

Reiterated

12/09/25

Buy Rating for Cullinan Management Driven by Promising CLN-049 Clinical Data and Strategic Development Plan

Robert Driscoll

Wedbush

$25→$34

Buy

231.38%

Upside

Reiterated

12/09/25

Cullinan Therapeutics price target raised to $34 from $25 at WedbushCullinan Therapeutics price target raised to $34 from $25 at Wedbush

David Dai

UBS

$24

Buy

133.92%

Upside

Reiterated

12/09/25

We updated our model to incorporate 3Q25 results and maintain $24 PT.

Matt Phipps

William Blair

$23

Buy

124.17%

Upside

Assigned

12/08/25

Optimistic Buy Rating for Cullinan Management Driven by Promising CLN-049 Therapy Results

Soumit Roy

JonesTrading

$36

Buy

250.88%

Upside

Reiterated

12/08/25

Promising Outlook for Cullinan Management: Buy Rating Backed by Strong Therapeutic Developments and Financial Position

Robert Burns

H.C. Wainwright

$24→$26

Buy

153.41%

Upside

Reiterated

11/21/25

Optimistic Buy Rating for Cullinan Management Driven by Promising Drug Pipeline and Upcoming Catalysts

Andrew Berens

Leerink Partners

Buy

―

Reiterated

09/04/25

Cullinan Management's Strategic Adjustments and Pipeline Development Justify Buy Rating

Alex Thompson CFA

Stifel Nicolaus

$22

Buy

114.42%

Upside

Initiated

06/11/25

Cullinan Therapeutics resumed with a Buy at StifelCullinan Therapeutics resumed with a Buy at Stifel

Bradley Canino

Guggenheim

$30

Buy

192.40%

Upside

Reiterated

02/28/25

Cullinan Management (CGEM) Receives a Buy from Stifel Nicolaus

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Marc Frahm

TD Cowen

Buy

―

Reiterated

12/17/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Cullinan Management (NASDAQ: CGEM)

Kaveri Pohlman

Clear Street

$22→$33

Buy

221.64%

Upside

Reiterated

12/10/25

Cullinan Therapeutics price target raised to $33 from $22 at Clear StreetCullinan Therapeutics price target raised to $33 from $22 at Clear Street

Julian Harrison

BTIG

$38

Buy

270.37%

Upside

Reiterated

12/09/25

Cullinan Management (CGEM) Gets a Buy from BTIG

Sean Laaman

Morgan Stanley

$28

Buy

172.90%

Upside

Reiterated

12/09/25

Buy Rating for Cullinan Management Driven by Promising CLN-049 Clinical Data and Strategic Development Plan

Robert Driscoll

Wedbush

$25→$34

Buy

231.38%

Upside

Reiterated

12/09/25

Cullinan Therapeutics price target raised to $34 from $25 at WedbushCullinan Therapeutics price target raised to $34 from $25 at Wedbush

David Dai

UBS

$24

Buy

133.92%

Upside

Reiterated

12/09/25

We updated our model to incorporate 3Q25 results and maintain $24 PT.

Matt Phipps

William Blair

$23

Buy

124.17%

Upside

Assigned

12/08/25

Optimistic Buy Rating for Cullinan Management Driven by Promising CLN-049 Therapy Results

Soumit Roy

JonesTrading

$36

Buy

250.88%

Upside

Reiterated

12/08/25

Promising Outlook for Cullinan Management: Buy Rating Backed by Strong Therapeutic Developments and Financial Position

Robert Burns

H.C. Wainwright

$24→$26

Buy

153.41%

Upside

Reiterated

11/21/25

Optimistic Buy Rating for Cullinan Management Driven by Promising Drug Pipeline and Upcoming Catalysts

Andrew Berens

Leerink Partners

Buy

―

Reiterated

09/04/25

Cullinan Management's Strategic Adjustments and Pipeline Development Justify Buy Rating

Alex Thompson CFA

Stifel Nicolaus

$22

Buy

114.42%

Upside

Initiated

06/11/25

Cullinan Therapeutics resumed with a Buy at StifelCullinan Therapeutics resumed with a Buy at Stifel

Bradley Canino

Guggenheim

$30

Buy

192.40%

Upside

Reiterated

02/28/25

Cullinan Management (CGEM) Receives a Buy from Stifel Nicolaus

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cullinan Management

1 Month

xxx

Success Rate

5/13 ratings generated profit

Average Return

+2.32%

reiterated a xxx

rating 17 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 38.46% of your transactions generating a profit, with an average return of +2.32% per trade.

3 Months

xxx

Success Rate

5/12 ratings generated profit

Average Return

-3.62%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 41.67% of your transactions generating a profit, with an average return of -3.62% per trade.

1 Year

Marc FrahmTD Cowen

Success Rate

10/17 ratings generated profit

Average Return

-4.89%

reiterated a buy rating 10 days ago

Copying Marc Frahm's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of -4.89% per trade.

2 Years

xxx

Success Rate

7/12 ratings generated profit

Average Return

+2.42%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 58.33% of your transactions generating a profit, with an average return of +2.42% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CGEM Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CGEM has received 25 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CGEM average Analyst price target in the past 3 months is 30.25.

Each month's total comprises the sum of three months' worth of ratings.

CGEM Financial Forecast

CGEM Earnings Forecast

Next quarter’s earnings estimate for CGEM is -$0.79 with a range of -$0.99 to -$0.49. The previous quarter’s EPS was -$0.77. CGEM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year CGEM has Performed in-line its overall industry.

No data currently available

CGEM Sales Forecast

Next quarter’s sales forecast for CGEM is $6.25M with a range of $0.00 to $50.00M. The previous quarter’s sales results were $0.00. CGEM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year CGEM has Performed in-line its overall industry.

CGEM Stock Forecast FAQ

What is CGEM’s average 12-month price target, according to analysts?

Based on analyst ratings, Cullinan Management’s 12-month average price target is 30.25.

What is CGEM’s upside potential, based on the analysts’ average price target?

Cullinan Management has 194.83% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CGEM a Buy, Sell or Hold?

Cullinan Management has a consensus rating of Strong Buy which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.

What is Cullinan Management’s price target?

The average price target for Cullinan Management is 30.25. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $38.00 ,the lowest forecast is $23.00. The average price target represents 194.83% Increase from the current price of $10.26.

What do analysts say about Cullinan Management?

Cullinan Management’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of CGEM?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Cullinan Management (CGEM) Stock Forecast & Price Target

CGEM Analyst Ratings

CGEM Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cullinan Management

CGEM Analyst Recommendation Trends

CGEM Financial Forecast

CGEM Earnings Forecast

CGEM Sales Forecast

CGEM Stock Forecast FAQ

Detailed List of Analyst Forecasts